What We're Reading: Page 279
Industry reads hand-picked by our editors
Dec 13, 2017
-
Politico
Why a drug for aging would challenge Washington
-
Chemical & Engineering News
CRISPR gene editing is coming to the clinic
-
Fortune
Why American entrepreneurs need to study China’s biotech strategy
Dec 12, 2017
Dec 11, 2017
Dec 08, 2017
-
Kaiser Health News
Cities, counties and schools sidestep FDA Canadian drug crackdown, saving millions
-
Bloomberg
Charity delays giving new aid after U.S. faults pharma ties
-
Genetic Engineering & Biotechnology News
Improvements to gene therapy clinical trial design benefit hemophilia patients
-
Los Angeles Times
FDA's program to speed up drug approval shaved nearly a year off the process
Dec 07, 2017
Dec 06, 2017
-
Medical Marketing & Media
How will the pharma industry fare in 2018 under Trump?
-
The Wall Street Journal
Pharma’s helping hand may pinch investors
-
Reuters
Merck to Supreme Court: The rules are different in pharma cases
-
Bloomberg
Sex, drugs and that little blue pill
Previous
